{"id":70699,"date":"2026-05-12T09:19:23","date_gmt":"2026-05-12T09:19:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70699"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"selank","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/selank\/","title":{"rendered":"Selank"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 il Selank?<\/h3>\n<p style=\"margin: 0;\"><strong>Selank<\/strong> is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">129954-34-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">751.88 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH<sub>2<\/sub> (TKPRPGP-NH<sub>2<\/sub>, 7 amminoacidi; analogo amidato della tuftsina al C-terminale)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvere liofilizzata (da bianca a biancastra)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 il Selank?<\/h2>\n<p><strong>Selank<\/strong> is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a>. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank&#8217;s well-characterised sequence is TKPRPGP-NH<sub>2<\/sub>, peso molecolare 751.88 Da, formula empirica C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> pagina prodotto. <\/p>\n<h2>Meccanismo d'azione - Vie GABAergiche, serotoninergiche e BDNF<\/h2>\n<p>What makes Selank distinctive among anxiolytic compounds is its <strong>profilo neuromodulatorio multi-via<\/strong> senza legame diretto al recettore GABA<sub>A<\/sub> benzodiazepine site \u2014 each contributing to the observed anxiolytic and nootropic phenotype in published studies:<\/p>\n<ul>\n<li><strong>Modulazione GABAergica senza legame al sito delle benzodiazepine<\/strong> \u2014 Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank&#8217;s pharmacology.<\/li>\n<li><strong>Segnalazione serotoninergica ed encefalinergica<\/strong> \u2014 Published studies has documented increased serotonin metabolism (5-HIAA \/ 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.<\/li>\n<li><strong>Espressione del BDNF e neuroplasticit\u00e0<\/strong> \u2014 Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank&#8217;s nootropic profile \u2014 improved memory consolidation and learning performance in rodent maze tasks.<\/li>\n<\/ul>\n<p>Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Selank is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Farmacologia ansiolitica<\/strong> \u2014 test del labirinto elevato, del campo aperto e di interazione sociale nei modelli di roditori di ansia generalizzata; bracci comparativi contro benzodiazepine (diazepam) e SSRI (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)<\/li>\n<li><strong>Stress resilience and HPA-axis studies<\/strong> \u2014 modelli di stress cronico lieve, stress da restrizione e impotenza appresa; dinamiche del cortisolo e dell'ACTH<\/li>\n<li><strong>BDNF and neuroplasticity studies<\/strong> \u2014 espressione del BDNF nell'ippocampo e nella corteccia prefrontale, morfologia delle spine dendritiche, elettrofisiologia della potenziazione a lungo termine<\/li>\n<li><strong>Cognitive and memory studies<\/strong> \u2014 Labirinto acquatico di Morris, riconoscimento di nuovi oggetti, evitamento passivo; effetti nootropici indipendenti dall'ansiolisi<\/li>\n<li><strong>Immunomodulazione<\/strong> \u2014 Selank inherits tuftsin&#8217;s immunomodulatory activity, with documented effects on cytokine balance (TNF-\u03b1, IL-6, IFN-\u03b3) and macrophage function in published studies<\/li>\n<li><strong>Comparative studies vs benzodiazepines<\/strong> \u2014 confronto diretto con diazepam, alprazolam e fenazepam sull'efficacia ansiolitica, potenziale di dipendenza e rebound; il profilo di sospensione pulito di Selank \u00e8 uno dei risultati pi\u00f9 citati nella letteratura russa<\/li>\n<li><strong>Sister-peptide studies<\/strong> \u2014 benchmarking rispetto a <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.<\/li>\n<\/ul>\n<p>For broader context on small-peptide neuromodulation and nootropic studies, see <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> come il comparatore nootropico canonico sviluppato in Russia, <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/it\/bpc-157\/\">BPC-157<\/a> for the parallel small-peptide healing-compound. Browse the full <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a> per composti correlati. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, intranasal-vehicle formulation studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols. <\/p>\n<h2>Confronto \u2014 Selank vs Semax<\/h2>\n<p>Selank e <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic\/neuroprotective. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lunghezza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 aminoacidi (eptapeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 aminoacidi (eptapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peptide genitore<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tuftsin (TKPR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frammento ACTH(4-10)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meccanismo primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Modulazione GABA, BDNF, encefalina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BDNF, recettori melanocortinici, dopamina<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiolitico, resilienza allo stress<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootropico, neuroprotettivo, concentrazione<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg\/giorno<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u20131.000 mcg\/giorno<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso clinico russo<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiolitico approvato (intranasale)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootropico\/recupero da ictus approvato (intranasale)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking in studies<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente combinato con Semax per un effetto ansiolitico+nootropico complementare<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequentemente combinato con Selank<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because the two peptides act on complementary axes \u2014 Selank on GABA\/anxiolytic, Semax on melanocortin\/dopaminergic\/nootropic \u2014 they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> Conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale per lo stock di lavoro a breve termine. Per lo stoccaggio a lungo termine non aperto, congelare a \u221220 \u00b0C. Selank liofilizzato \u00e8 stabile in refrigerazione fino a 24 mesi e a \u221220 \u00b0C fino a 36 mesi. Evitare cicli di congelamento-scongelamento sulla polvere liofilizzata. <strong>Procedura di ricostituzione:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 1.0\u00a0mL of bacteriostatic water yields a 5\u00a0mg\/mL working concentration; 0.1\u00a0mL delivers a 500\u00a0mcg dose. Swirl gently \u2014 do <strong>not<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Dopo la ricostituzione:<\/strong> Conservare in frigorifero a 2\u20138\u00b0C e utilizzare entro 30 giorni per una stabilit\u00e0 ottimale. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano l'integrit\u00e0 del peptide. Scartare qualsiasi flaconcino che presenti torbidit\u00e0, precipitato o scolorimento. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is Selank used for in studies?<\/h3>\n<p>Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is <strong>not<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>In cosa differisce il Selank dal Semax?<\/h3>\n<p>Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways \u2014 canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation \u2014 canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping. <\/p>\n<h3>What is the typical Selank dose?<\/h3>\n<p>Published Russian protocols typically use 300\u2013900\u00a0mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5\u00a0mg vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 0.1\u00a0mL equals 500\u00a0mcg, a typical single-dose studies aliquot. <\/p>\n<h3>Il Selank \u00e8 approvato dalla FDA?<\/h3>\n<p>No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez). <\/p>\n<h3>Come deve essere conservato il Selank?<\/h3>\n<p>Flaconcini liofilizzati: refrigerati a 2-8 \u00b0C per scorte di lavoro a breve termine, o -20 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Soluzione ricostituita: refrigerata a 2-8 \u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita - i cicli di congelamento-scongelamento degradano il peptide. Proteggere sempre dalla luce diretta. <\/p>\n<h3>Come si ricostituisce il Selank?<\/h3>\n<p>Seguire la procedura di ricostituzione sopra indicata. Aggiungere acqua batteriostatica lungo la parete laterale del flaconcino (non direttamente sulla polvere liofilizzata), agitare delicatamente e attendere 2-5 minuti per la completa dissoluzione. Non <strong>not<\/strong> Agitare il flaconcino. Una soluzione correttamente ricostituita \u00e8 limpida e incolore. Per un flaconcino da 5 mg + 1,0 mL di diluente, la concentrazione di lavoro \u00e8 di 5 mg\/mL. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase carries Selank in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Selank be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models. <\/p>\n<h3>Can Selank and Semax be stacked in studies?<\/h3>\n<p>Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA\/enkephalin\/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin\/dopaminergic\/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress. <\/p>\n<h3>Does Selank cause side reported effects?<\/h3>\n<p>Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation \u2014 in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review. <\/p>\n<h3>Qual \u00e8 l'emivita del Selank?<\/h3>\n<p>In preclinical studies, Selank has an estimated plasma half-life of approximately 15\u201330 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance. <\/p>\n<h3>How long does Selank take to show effects in preclinical studies?<\/h3>\n<p>Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30\u201360 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7\u201314 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models. <\/p>\n<h3>Posso ordinare Selank per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce Selank in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione peptidi autonomo. Tutti gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo e sono coperti dal nostro <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\">Politica di Garanzia di Rispedizione<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies<\/h2>\n<ul>\n<li><a href=\"\/it\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Sister heptapeptide from the same Russian clinical \u2014 nootropic and neuroprotective studies<\/li>\n<li><a href=\"\/it\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<li><a href=\"\/it\/kpv-lysine-proline-valine\/\"><strong>KPV<\/strong><\/a> \u2014 Small immunomodulatory tripeptide \u2014 inflammation and barrier studies<\/li>\n<li><a href=\"\/it\/adamax\/\"><strong>Adamax<\/strong><\/a> \u2014 Heptapeptide nootropic compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore small-peptide nootropic studies<\/strong><\/p>\n<p style=\"margin: 0;\">Sfoglia l'intera <a href=\"https:\/\/medsbase.com\/it\/peptides\/\"><strong>catalogo peptidi<\/strong><\/a>, con composti correlati tra cui <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> for melanocortin-axis nootropic studies, <a href=\"https:\/\/medsbase.com\/it\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/it\/adamax\/\">Adamax<\/a> for sister heptapeptide cognitive studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Ansiolitico senza sedazione<br \/>\n\u2705 Modulazione multi-via di GABA \/ BDNF \/ encefalina<br \/>\n\u2705 Stress-resilience compound<br \/>\n\u2705 Peptide biodisponibile per via intranasale<br \/>\n\u2705 Profilo di sospensione pulito rispetto alle benzodiazepine<\/p>\n<p><strong>Selank<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70977,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,6273],"class_list":["post-70699","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-selank","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/70699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=70699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70977"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=70699"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=70699"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=70699"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=70699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}